Thematic

Causal claim

Otsuka ✚ Antipsychotic Treatment

Otsuka enables Antipsychotic Treatment.

The two move together: more cause, more effect. The map scores it at 30% confidence, weighed from 1 article.

• EnablesRelation
• +Polarity
• 30%Confidence
• variesLag
• ModerateStrength
• ActiveStatus

How it works

Otsuka (with Bristol-Myers Squibb) developed and markets aripiprazole (Abilify), FDA-approved since September 2004 for acute manic and mixed episodes of bipolar I.

The evidence

• N

  U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Add-On Treatment to Lithium or Valproate in the Acute Treatment of Adults With Manic and Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features

  news.bms.com Standard

  Backs 1 claim

  • Otsuka ✚ Antipsychotic Treatment

  Read article →

Where it sits

See it on the live map →